Hey all, I just wanted to create a thread to discuss EOF's future.
EOF has high potential in the coming year as the legalization of OTC medicines is around the corner; they have put a lot of resources into clinical trials. I believe they are one of the frontrunners, bringing good revenue once approved.
The price is at all-time lows, and the companies profits have turned negative. Th
e company operating costs are 26mill per year, and cash reserves are almost empy.
I believe a Capital raising is around the corner to provide the capital to fund further research, marketing and phase 3 clinical trials.
This is just my opinion keen to hear others,GL everyone
Bump-Whats coming ?
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EOF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.63M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 11176 | 2 |
View Market Depth
| Last trade - 16.12pm 11/07/2024 (20 minute delay) ? |
| EOF (ASX) Chart |
Day chart unavailable